Table of contents
Fragmented communication. Manual data exchanges. Limited insight beyond tier 1 suppliers. According to Matthias Leimer, VP of Supply Chain Transformation at Genpact, these long-standing challenges are holding life sciences supply chains back—and digitalization is the key to breaking through.
In this FutureLink Boston 2025 session, Leimer explores why technology alone isn't enough to transform supply networks. Drawing on real-world experiences with pharmaceutical, biotech, and medtech companies, he explains why meaningful transformation requires a rethinking of organizational processes, data ownership, and supplier collaboration models. He also shares why Genpact sees TraceLink as a co-innovation partner in solving some of the industry's most urgent challenges—particularly when it comes to external manufacturing and planning alignment.
Watch to learn:
- Why supplier collaboration—not just planning systems—is the next frontier of transformation
- How a tiered supplier segmentation strategy supports scalable digitalization
- How Genpact and TraceLink are working together to enable exception-based planning and eliminate data silos
Watch the full session now to learn how to drive lasting supply chain transformation.
